Therapy-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.

Pamela Maxwell; David Waugh; Melissa LaBonte Wilson

Therapy-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.

Pamela Maxwell, David Waugh, Melissa LaBonte Wilson^*

^*Corresponding author for this work

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 28 Nov 2017
Event	European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom Duration: 25 Nov 2017 → 29 Nov 2017

Conference

Conference	European Alliance for Personalised Medicine Conference
Country/Territory	United Kingdom
City	Belfast
Period	25/11/2017 → 29/11/2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{95de583db1e1437ba45f42ebd057d9fe,

title = "Therapy-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.",

author = "Pamela Maxwell and David Waugh and {LaBonte Wilson}, Melissa",

year = "2017",

month = nov,

day = "28",

language = "English",

note = "European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” ; Conference date: 25-11-2017 Through 29-11-2017",

}